TRCT
CURE icon

Tower Research Capital (TRC)’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Tower Research Capital (TRC)’s Portfolio CURE Stock Details CURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.1K Sell
438
-5,286
-92% -$574K ﹤0.01% 2945
2025
Q4 		$639K Sell
5,724
-40,134
-88% -$4.11M 0.02% 697
2025
Q3 		$3.83M Buy
45,858
+43,236
+1,649% +$3.37M 0.11% 161
2025
Q2 		$207K Sell
2,622
-667
-20% -$53.9K 0.01% 1746
2025
Q1 		$351K Buy
3,289
+3,092
+1,570% +$329K 0.01% 1057
2024
Q4 		$18.2K Sell
197
-390
-66% -$43.9K ﹤0.01% 3266
2024
Q3 		$78.2K Sell
587
-1,363
-70% -$175K ﹤0.01% 2435
2024
Q2 		$228K Sell
1,950
-233
-11% -$26.3K ﹤0.01% 1964
2024
Q1 		$274K Buy
2,183
+1,923
+740% +$224K 0.01% 1213
2023
Q4 		$26.5K Sell
260
-1,343
-84% -$120K ﹤0.01% 3491
2023
Q3 		$142K Sell
1,603
-2,205
-58% -$217K ﹤0.01% 1705
2023
Q2 		$381K Sell
3,808
-3,900
-51% -$388K 0.01% 1149
2023
Q1 		$740K Buy
7,708
+7,395
+2,363% +$742K 0.02% 606
2022
Q4 		$36K Sell
313
-5,199
-94% -$562K ﹤0.01% 2582
2022
Q3 		$465K Buy
+5,512
New +$569K 0.01% 1204
2022
Q2 		– Sell
-916
Closed -$120K – 6133
2022
Q1 		$120K Buy
+916
New +$109K ﹤0.01% 2072
2021
Q4 		– Sell
-744
Closed -$80K – 6192
2021
Q3 		$80K Sell
744
-31
-4% -$3.73K ﹤0.01% 2588
2021
Q2 		$81K Sell
775
-1,932
-71% -$186K ﹤0.01% 2590
2021
Q1 		$226K Sell
2,707
-5,082
-65% -$410K ﹤0.01% 1906
2020
Q4 		$600K Buy
7,789
+4,480
+135% +$308K 0.02% 858
2020
Q3 		$209K Sell
3,309
-9,801
-75% -$615K ﹤0.01% 2538
2020
Q2 		$712K Buy
+13,110
New +$696K 0.03% 745
2020
Q1 		– Sell
-5,764
Closed -$425K – 3179
2019
Q4 		$425K Sell
5,764
-5,422
-48% -$331K 0.04% 320
2019
Q3 		$566K Sell
11,186
-9,492
-46% -$503K 0.04% 530
2019
Q2 		$1.16M Sell
20,678
-9,627
-32% -$496K 0.08% 224
2019
Q1 		$1.69M Buy
30,305
+22,153
+272% +$1.18M 0.1% 154
2018
Q4 		$388K Buy
+8,152
New +$458K 0.03% 491
2018
Q3 		– Sell
-55,597
Closed -$2.52M – 3836
2018
Q2 		$2.52M Buy
55,597
+41,777
+302% +$1.87M 0.14% 130
2018
Q1 		$595K Buy
13,820
+12,616
+1,048% +$634K 0.05% 389
2017
Q4 		$56K Sell
1,204
-7,430
-86% -$344K 0.01% 1248
2017
Q3 		$393K Buy
8,634
+5,929
+219% +$256K 0.03% 346
2017
Q2 		$113K Sell
2,705
-6,076
-69% -$225K 0.01% 453
2017
Q1 		$303K Sell
8,781
-41,995
-83% -$1.37M 0.03% 217
2016
Q4 		$1.4M Buy
50,776
+5,295
+12% +$149K 0.15% 151
2016
Q3 		$1.45M Buy
45,481
+1,840
+4% +$62.5K 0.14% 64
2016
Q2 		$1.38M Buy
43,641
+27,939
+178% +$842K 0.13% 118
2016
Q1 		$426K Sell
15,702
-29,239
-65% -$770K 0.06% 194
2015
Q4 		$1.5M Buy
+44,941
New +$1.42M 0.24% 59
2015
Q2 		– Sell
-15,415
Closed -$453K – 4468
2015
Q1 		$453K Sell
15,415
-3,705
-19% -$103K 0.06% 188
2014
Q4 		$476K Buy
+19,120
New +$449K 0.05% 131
2014
Q3 		– Sell
-134,130
Closed -$2.4M – 4476
2014
Q2 		$2.4M Buy
+134,130
New +$2.16M 0.31% 36

Other funds holding CURE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
OBWG
Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return
PWPS
Pinnacle Wealth Planning Services Mansfield, Ohio $968M AUM 19.1% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Tower Research Capital (TRC)'s CURE Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Direxion Daily Healthcare Bull 3X ETF (CURE) stake by 92% in Q1 2026, selling an estimated $574K and leaving 438 shares worth $40.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2945.

Tower Research Capital (TRC) first reported a position in CURE in Q2 2014 and has held it in 41 quarters since. The position peaked at $3.83M in Q3 2025. 15 funds tracked by Wall St. Rank hold CURE as of Q1 2026.

  • Tower Research Capital (TRC) held 438 shares of Direxion Daily Healthcare Bull 3X ETF worth $40.1K as of Q1 2026.
  • Tower Research Capital (TRC) sold 5,286 Direxion Daily Healthcare Bull 3X ETF shares in Q1 2026, an estimated $574K.
  • Direxion Daily Healthcare Bull 3X ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2945 holding.
  • Tower Research Capital (TRC) first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q2 2014 and has held it in 41 quarters since.
  • Tower Research Capital (TRC)'s Direxion Daily Healthcare Bull 3X ETF position peaked at $3.83M in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.